|
|
| Research article summary (published 30 Jan 2002): |
Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
Full Abstract
In Alzheimer's disease (AD), loss of cortical and hippocampal choline acetyltransferase (ChAT) activity has been correlated with dementia severity and disease duration, and it forms the basis for current therapies. However, the extent to which reductions in ChAT activity are associated with early cognitive decline has not been well established. We quantified ChAT activity in the hippocampus and four cortical regions (superior frontal, inferior parietal, superior temporal, and anterior cingulate) of 58 individuals diagnosed with no cognitive impairment (NCI; n = 26; mean age 81.4 +/- 7.3 years), mild cognitive impairment (MCI; n = 18; mean age 84.5 +/- 5.7), or mild AD (n =14; mean age 86.3 +/- 6.6). Inferior parietal cortex ChAT activity was also assessed in 12 subjects with end-stage AD (mean age 81.4 +/- 4.3 years) and compared to inferior parietal cortex ChAT levels of the other three groups. Only the end-stage AD group had ChAT levels reduced below normal. In individuals with MCI and mild AD, ChAT activity was unchanged in the inferior parietal, superior temporal, and anterior cingulate cortices compared to NCI. In contrast, ChAT activity in the superior frontal cortex was significantly elevated above normal controls in MCI subjects, whereas the mild AD group was not different from NCI or MCI. Hippocampal ChAT activity was significantly higher in MCI subjects than in either NCI or AD. Our results suggest that cognitive deficits in MCI and early AD are not associated with the loss of ChAT and occur despite regionally specific upregulation. Thus, the earliest cognitive deficits in AD involve brain changes other than simply cholinergic system loss. Of importance, the cholinergic system is capable of compensatory responses during the early stage of dementia. The upregulation in frontal cortex and hippocampal ChAT activity could be an important factor in preventing the transition of MCI subjects to AD.
Learn Faster Today Improve your study skills
Author information
Author/s: DeKosky, Steven T (ST); Ikonomovic, Milos D (MD); Styren, Scot D (SD); Beckett, Laurel (L); Wisniewski, Stephen (S); Bennett, David A (DA); Cochran, Elizabeth J (EJ); Kordower, Jeffrey H (JH); Mufson, Elliott J (EJ);
Affiliation: Department of Neurology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. dekoskyst(-atsign-)msx.upm.edu
Grants: AG05133 (Agency:NIA NIH HHS) ; AG10161 (Agency:NIA NIH HHS) ; AG14449 (Agency:NIA NIH HHS)
Journal and publication information
Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
Journal: Annals of neurology (Ann Neurol), published in United States. (Language: eng)
Reference: 2002-Feb; vol 51 (issue 2) : pp 145-55
Dates: Created 2002/02/08; Completed 2002/03/01; Revised 2007/11/14;
PMID: 11835370, status: MEDLINE (last retrieval date: 12/26/2008)
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
Comments and Corrections
CommentIn: Ann Neurol. 2002 Feb;51(2):143-4. (PMID: 11835369)
External Links for this article (including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
|
|
Related articles
These are the highest related articles currently in the database:
- Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients.
30 Dec 1999 - Differential involvement of 5-HT(1B/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer's disease.
30 Jan 2004 - White matter lesions impair frontal lobe function regardless of their location.
25 Jul 2004 - Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
29 Nov 2002 - Cholinergic dysfunction in diseases with Lewy bodies.
23 Jan 2000 - Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease.
20 Sep 2000 - Relationship between Alzheimer's disease clinical stage and Gq/11 in subcellular fractions of frontal cortex.
5 Dec 2004 - Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
30 May 2005 - Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
Apr 2006 - Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
5 Mar 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.